False Positives In The Diagnosis Of Sexually Transmitted Chlamydia Trachomatis Infection In Children
Funder
National Health and Medical Research Council
Funding Amount
$724,313.00
Summary
Chlamydia trachomatis causes sexually transmitted infections, and also the eye disease trachoma. The detection of Chlamydia in urine sample from a child can be seen as evidence for sexual abuse. We will assess the potential impacts of three mechanisms that could conceivably lead to urogenital Chlamydia diagnosis in a child in the absence of sexual abuse: contamination of the urogenital site with ocula Chlamydia, contamination of urine samples after collection, and diagnostic test malfunction.
Uptake, Sustainability And Impact Of Scaling Up Point-of-care Testing For Sexually Transmissible Infections In Remote And Regional Aboriginal Communities
Funder
National Health and Medical Research Council
Funding Amount
$1,461,788.00
Summary
Aboriginal youth experience unacceptably high rates of curable sexually transmissible infections (STI). Coverage of testing and treatment is insufficient for disease control but could be enhanced via point-of-care (POC) testing. We have been trialling a highly accurate STI/POC diagnostic in the TTANGO (Test, Treat ANd GO) trial. The TTANGO2 partnership will assess the long-term uptake, sustainability and impact of POC testing in 20 Aboriginal health services in regional/remote WA over 5 years.
Genital Chlamydia infections have increased over 4-fold in the last decade. Untreated infections lead to pelvic inflammatory disease, ectopic pregnancy and infertility. These conditions are due to the inflammatory immune response elicited by infections that cause scarring and oviduct blockage. The proposed studies will determine how the immune system causes tissue damage and how this damage can be avoided to enable the development a vaccine that protects women against infection and infertility.
New Technologies To Reduce The Population Burden Of Sexually Transmitted Infections
Funder
National Health and Medical Research Council
Funding Amount
$772,605.00
Summary
I propose a five year program of public health research on the evaluation of innovative technologies to prevent sexually transmitted infections (STIs) and their adverse consequences in populations at highest risk; Aboriginal and Torres Strait Islander people, youth, men who have sex with men and people in high STI-burden resource-limited countries. My research over the next five years will lead to substantial improvements in the health of people at greatest risk of STIs.
Enhanced Prevention And Control Of Sexually Transmitted Infections
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
The entire developed world is witnessing dramatic increases in bacterial sexually transmitted infections (STIs), the likes of which have not been seen since prior to the emergence of the HIV epidemic in the 1980s. My vision is to reduce the burden of STIs by identifying innovative, cost-effective approaches to STI prevention and management that are acceptable to the populations affected (including healthcare workers and people are risk of STIs) and able to be implemented on a broad scale.
An Evidence Based Framework For Establishing Public Health Microbial Genomics In Australia
Funder
National Health and Medical Research Council
Funding Amount
$1,413,093.00
Summary
Microbial genomics is a powerful laboratory tool to characterise human pathogens at the highest level, allowing greater understanding of the source and spread of pathogens that infect humans. In this project, through close links with the Victorian Government, we will determine how this exciting new technology can best be applied to prevent the spread of high risk human pathogens, and inform public health action.
DEVELOPING AND EVALUATING NOVEL STRATEGIES FOR THE CONTROL OF SYPHILIS IN PRIORITY POPULATIONS
Funder
National Health and Medical Research Council
Funding Amount
$390,921.00
Summary
My Post Doctoral studies will assess the natural history of human papillomavirus (HPV) in men who have sex with men (MSM) and novel strategies aimed at increasing testing and early detection of HIV and other sexually transmitted infection (STIs). These studies will be conducted at the Kirby Institute (KI), the Chinese National Center for AIDS/STD Control and Prevention, Beijing (NCAIDS) and the Wuxi Center for Disease Control and Prevention (CDC), Wuxi, China, and potentially other institutions.
Antibiotic Treatment Of Male Partners To Reduce Recurrence Of Bacterial Vaginosis In Women: A Randomised Double-blind Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$636,674.00
Summary
Bacterial vaginosis (BV) is the most common vaginal infection in women. Healthy bacteria are lost and replaced by bacteria that cause unpleasant discharge and odour. BV puts women at increased risk of sexually transmitted infections, HIV, miscarriage and preterm delivery. Over 50% of women given antibiotics get BV back again. Studies suggest these bacteria are being sexually transmitted. We are conducting a trial of antibiotic treatment of women and their male partners to improve BV cure.
A Randomised Controlled Trial (RCT) Of Azithromycin Versus Doxycycline For The Treatment Of Rectal Chlamydia Infection In Men Who Have Sex With Men.
Funder
National Health and Medical Research Council
Funding Amount
$797,906.00
Summary
Rectal chlamydia is very common among gay men; it can exist for long periods without symptoms leading to ongoing transmission. Azithromycin (1 gram single dose) or 7 days doxycycline (100mg twice daily) are the two recommended treatments globally. But, there is concern about rectal chlamydia treatment with reports of up to 22% failure following azithromycin. We will conduct a randomised trial to compare these treatments for rectal chlamydia and determine which drug works better.